Latest filing published 15 Jun 2023 for Mirum Pharmaceuticals, Inc..
Insider track record
No signal scores available.
NEA Partners 16, L.P.: trading record in brief
All filings by NEA Partners 16, L.P. on record concern Mirum Pharmaceuticals, Inc. In total, 3 filings cover trades dated 13 June 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 15 June 2023 came the latest disclosure, a transaction in Mirum Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to NEA Partners 16, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares0Common StockSEC:0001209191-23-037343:1
- 30,000 shares0Common StockSEC:0001209191-23-037343:2
- 2,000,000 shares0Common StockSEC:0001209191-23-037343:0
3 of 3 declarations
